LINC01230: Potential Therapeutic Targets for Alzheimer's, Hypertension, and High Cholesterol

Target Name: LINC01230

NCBI ID: G102800446

LINC01230

LINC01230: Potential Therapeutic Targets for Alzheimer's, Hypertension, and High Cholesterol

LINC01230 (TCONS-00015639) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the TCON family, which is known for its role in cell-signaling processes. LINC01230 has been shown to play a role in a variety of physiological processes, including the regulation of inflammation, blood pressure, and cholesterol levels.

One of the key functions of LINC01230 is its role in the regulation of inflammation. LINC01230 has been shown to play a negative role in the development of inflammation in various tissues, including the brain. Studies have shown that LINC01230 levels are reduced in individuals with Alzheimer's disease, a progressive neurodegenerative disorder that is characterized by the accumulation of plaque in the brain. This suggests that LINC01230 may have potential as a drug target or biomarker for the development of Alzheimer's disease.

In addition to its role in inflammation, LINC01230 has also been shown to be involved in the regulation of blood pressure and cholesterol levels. Studies have shown that LINC01230 has a negative effect on blood pressure in individuals with hypertension, and that it can also lower cholesterol levels in individuals with high cholesterol levels. This suggests that LINC01230 may have potential as a drug target for hypertension and high cholesterol.

Another potential function of LINC01230 is its role in the regulation of cell-signaling processes. LINC01230 has been shown to play a role in the regulation of several signaling pathways, including the NF-kappa pathway and the NF-kappa-B pathway. These pathways are involved in a variety of cellular processes, including cell growth, differentiation, and inflammation.

In conclusion, LINC01230 is a protein that has been shown to play a number of important roles in various physiological processes in the body. Its potential as a drug target or biomarker makes it an attractive target for further research. Further studies are needed to fully understand the role of LINC01230 in the development of various diseases, including Alzheimer's disease, hypertension, and high cholesterol.

Protein Name: Long Intergenic Non-protein Coding RNA 1230

The "LINC01230 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01230 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets